ロード中...
Disease progression patterns of bevacizumab responders with recurrent malignant gliomas
Tumor progression in patients with recurrent malignant glioma who respond to bevacizumab (BEV) is difficult to assess. The current study reviewed the clinical and radiological results of patients following a BEV-based chemotherapy regimen, and evaluated disease progression patterns in patients who r...
保存先:
| 出版年: | Oncol Lett |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5588053/ https://ncbi.nlm.nih.gov/pubmed/28927109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6630 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|